Nitazoxanide
NDC 13517-135, Nitazoxanide, tablet, from e5 Pharma, LLC.
- Product NDC
- 13517-135
- Status
- Listed
- Labeler
- e5 Pharma, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214844
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13517-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NITAZOXANIDE500 mg/1
Pharmacologic classes
Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13517-135-06 | 13517013506 | 6 TABLET in 1 BOTTLE (13517-135-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/40a7cc30-76cd-49fe-965a-7823c4140d0f
Use it
Look up 13517-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13517-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13517-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.